GNP Bioscience

GNP Bioscience is a South Korean biotechnology company specializing in the development of advanced drug delivery systems using gold nanoparticles (GNP). The company's core technology focuses on enhancing the efficacy and reducing the toxicity of existing chemotherapeutic agents by leveraging the unique physical and chemical properties of gold nanoparticles for targeted delivery. Their primary research efforts are directed toward oncology, with a focus on treating difficult-to-address solid tumors such as glioblastoma and head and neck cancers. By integrating targeting ligands and therapeutic payloads onto a nanoparticle scaffold, GNP Bioscience aims to provide more precise and effective treatment options for cancer patients.